1-Nitro-9,10-dioxo-9,10-dihydroanthracene-2-carboxylic acid, 97%, 250mg

Acide isobutyrique, >=99%, pour la synthèse, 1 L, emballage en verre

3-chloro-N-mesitylpropanamide, 95.0%, 5g

2-Ethynylpyridine, 95.0%, 25g

ethyl 5-amino-3-bromo-1H-pyrazole-4-carboxylate, 97%, 1g

5-(Bromomethyl)undecane, 95.0%, 5g

2-Bromo-3,6-difluorobenzoic acid, 95.0%, 5g

3-METHYLIMIDAZOLIDIN-4-ONE HCL, 95%, 250mg

3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile, 95%, 10mg

1-(4-(Phenylthio)phenyl)ethanone, 95.0%, 5g

2,6-Dimethoxyisonicotinic acid, 95.0%, 25g

2,6-Dihydroxy-3-cyano-4-methylpyridine, 95.0%, 5g